Lot-document scope confirmed before quotation · Research use only
  • Specification Review
  • Lot Documents on Request
  • Business Support · Xi’an
  • Destination Eligibility Confirmed
西安诺和达生物科技有限公司
For research, development and manufacturing use only. Not for human or veterinary use.

Metabolic & Weight Loss · Source-reviewed dossier

L-Carnitine

Source-Reviewed Research Dossier

L-Carnitine is a defined endogenous metabolite involved in transporting long-chain fatty acyl groups into mitochondria. The catalog family consolidates two solution strengths; clinical and nutrition literature does not validate the concentration, sterility or release quality of these research solutions.

Research use only Lot documents on request
L-Carnitine research product family with 2 catalog variants
AI-generated packaging mockup for catalog navigation. It is not a photograph of an actual supplied lot; container, label and presentation may vary.

Product family

Compound overview

Shared values below are consolidated from the current catalog record. They are not independent verification or lot results; the current product specification and lot COA control.

Product identity

Product type
Small-molecule research compound
Catalog family
L-Carnitine
Research category
Metabolic & Weight Loss
Catalog CAS RN
541-15-1
Catalog molecular formula
C7H15NO3
Catalog molecular weight
161.20 g/mol
Evidence status
Established biochemistry with heterogeneous supplementation evidence
Intended use
Research, development and manufacturing use only

Literature reference parameters

Compound or material class
Quaternary ammonium metabolite / fatty-acid transport cofactorCatalog-family identity
Evidence scope
Established biochemistry with heterogeneous supplementation evidenceDo not generalize beyond the cited model
Source review
Primary or authoritative records linked belowChecked 2026-09-01

Identity safeguard Reference identifiers above describe the literature compound record. The supplied form, formula, molecular weight, purity and storage conditions must be verified against the product-specific specification and lot COA.

Mechanism of action

How L-Carnitine is studied

A target-to-pathway view grounded in the linked research records.

Quaternary ammonium metabolite / fatty-acid transport cofactor research basis

Carnitine participates in the shuttle that transfers long-chain fatty acids across the inner mitochondrial membrane for β-oxidation.

Evidence and material boundary

Supplementation reviews combine different populations, routes and formulations and cannot be used as lot-specific evidence.

Reported research findings

What published studies report about L-Carnitine

Reported outcomes are paired with their experimental model and evidence boundary.

Biochemistry review

Carnitine function in fatty-acid transport is established

A foundational review describes carnitine biology, homeostasis and mitochondrial fatty-acid transport.

General physiology does not specify this catalog formulation.

Read the primary study
Literature review

Exercise-recovery findings are heterogeneous

A 2018 review examined L-carnitine supplementation and recovery-related outcomes across studies.

Different products, doses and populations prevent transfer to a catalog research solution.

Read the primary study
Translation boundary: findings are limited to the evidence level stated on each card. Experimental protocol quantities are research details, not usage instructions.

Catalog options

Variant specifications

Pack-level catalog data; lot-level controls remain document-specific.

Catalog no.LC600
Pack size10 ml × 10 vials
Specification & documents for LC600

Product specification

Small-molecule research compound · 10 ml/vial nominal · 10-vial pack · chemical form, identity and assay controlled by lot specification.

Lot documentation

Request by lot: CoA, identity and assay summary

Catalog no.LC1200
Pack size10 ml × 10 vials
Specification & documents for LC1200

Product specification

Small-molecule research compound · 10 ml/vial nominal · 10-vial pack · chemical form, identity and assay controlled by lot specification.

Lot documentation

Request by lot: CoA, identity and assay summary

Quality system

Quality documentation

Document availability is stated honestly and can vary by catalog variant or lot.

Lot-specific Certificate of AnalysisAvailability and scope must be confirmed for the selected catalog variant and lot
Confirm before ordering Request
Product Specification SheetAvailability and scope must be confirmed for the selected catalog variant and lot
Confirm before ordering Request
Analytical Method SummaryAvailability and scope must be confirmed for the selected catalog variant and lot
Confirm before ordering Request

Analytical interpretation

Interpret the documents, not just the headline number.

Use the source-reviewed guide to separate chromatographic area purity, quantitative assay, LC-MS identity, composition and stability evidence before comparing variants or requesting a lot record.

Open the Quality & Documentation Hub

HPLC area ≠ assayA dominant peak does not establish target mass fraction.

Intact mass ≠ full sequenceIdentity strength depends on resolution and orthogonal evidence.

Counterions affect contentWater, salt form and solvents change the as-is composition.

Storage needs a data basisShipping practice is not the same as stability evidence.

Evidence map

Research context

Published studies and regulatory records, not customer testimonials or usage guidance.

Biochemistry review

Carnitine function in fatty-acid transport is established

General physiology does not specify this catalog formulation.

View primary record
Literature review

Exercise-recovery findings are heterogeneous

Different products, doses and populations prevent transfer to a catalog research solution.

View primary record
Evidence boundary: each card states its evidence type. Human trials and regulatory records describe the studied or regulated intervention; preclinical records remain model-specific. None verifies the identity, quality, safety or efficacy of this catalog lot or provides usage instructions.

Literature basis

Curated references

Third-party publications selected for direct relevance.

  1. 01

    L-Carnitine

    Rebouche CJ. 1996. PMID 8758120.

    Biochemistry review
  2. 02

    L-Carnitine Supplementation in Recovery after Exercise

    Fielding R, et al. Nutrients. 2018. PMID 29534031.

    Literature review

Research FAQ

L-Carnitine questions

Concise answers for researchers comparing identity, evidence and catalog variants.

What is L-Carnitine?

L-Carnitine is a defined endogenous metabolite involved in transporting long-chain fatty acyl groups into mitochondria. The catalog family consolidates two solution strengths; clinical and nutrition literature does not validate the concentration, sterility or release quality of these research solutions.

What evidence is available for L-Carnitine?

Biochemical function is established, while outcome evidence varies by population and study design.

Does the cited research validate this catalog material?

No. The cited records describe their own intervention, formulation, model and controls. They do not verify the identity, purity, sterility, safety or efficacy of a catalog lot.

Which quality documents can be requested?

A lot-specific COA, product specification sheet and analytical method summary can be requested where applicable.

How should L-Carnitine be stored?

Store at 2-8 °C. Do not freeze. Protect from light. Confirm the applicable storage statement on the product-specific specification and lot documentation.

Knowledge tools

Continue with structured evidence

Move from this dossier into canonical evidence maps, verified status records, analytical interpretation and laboratory calculations.

Internal technical source review

Claims were checked against the linked primary publication, regulatory label or authoritative compound record. Published findings stay attached to their study model, formulation and route. Catalog identity and lot quality remain controlled by the applicable specification and lot-specific documents.

Editorial status: NHD evidence editorial workflow · 2026-09-01 · Not independent medical review · Review policy

Technical procurement

Ready to request a quote?

Selected: LC1200 · 10 ml × 10 vials